Download PDF
Pharmacopsychiatry 2009; 42(3): 89-94
DOI: 10.1055/s-0028-1103295
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Rivastigmine Reduces Tobacco Craving in Alcohol-dependent Smokers

A. Diehl 1 , H. Nakovics 1 , J. Mutschler 1 , D. Hermann 1 , F. Kiefer 1
  • 1Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health Mannheim, University of Heidelberg, Germany
Further Information

Publication History

received 26.03.2008 revised 15.10.2008

accepted 21.10.2008

Publication Date:
18 May 2009 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction: Although alcohol-dependent smokers represent an important group for applying smoking interventions, a sufficient pharmacotherapy has not been established in this high-risk group so far.

Methods: In order to examine the effect of the acetylcholinesterase inhibitor rivastigmine on tobacco dependence, we performed a 12-week, randomized, placebo-controlled trial. 26 alcohol-dependent smokers were randomized to rivastigmine 6 mg/day (n=14) or placebo (n=12). Assessments on addictive behavior included carbon monoxide (CO), severity of tobacco dependence (FTND), daily smoked cigarettes (diaries), and craving for tobacco (QSU) and alcohol (AUQ).

Results: ANOVA revealed a significant treatment-by-time interaction for tobacco consumption and tobacco craving (each p<0.0001). The rivastigmine group showed a decrease in daily smoked cigarettes (−30%), in exhaled carbon monoxide (−32%) and in tobacco craving (−18%) whereas controls did not show significant changes. ANCOVA revealed rivastigmine effects to be more prominent in smokers suffering from more severe tobacco dependence. None of the patients developed an alcohol relapse or an increase in alcohol craving.

Discussion: Our preliminary data indicate an effect of rivastigmine on tobacco craving and consumption. This pilot study encourages further investigation of acetylcholinesterase-inhibitors as a promising treatment approach regarding tobacco dependence.

References

  • 1 Assion HJ, Jungck C. Off-label prescribing in a German psychiatric hospital.  Pharmacopsychiatry. 2007;  40 30-36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Bobo JK, MacIlvain HE, Lando HA. et al . Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community intervention trial.  Addiction. 1998;  93 877-887
    CrossrefPubMedGoogle Scholar
  • 3 Bohn MJ, Krahn DD, Staehler BA. Development and initial validation of a measure of drinking urges in abstinent alcoholics.  Alcohol Clin Exp Res. 1995;  19 600-606
    CrossrefPubMedGoogle Scholar
  • 4 Dani JA, Heinemann S. Molecular and cellular aspects of nicotine abuse.  Neuron. 1996;  16 905-908
    CrossrefPubMedGoogle Scholar
  • 5 Diaz FJ, Santoro V, Spina E. et al . Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.  Pharmacopsychiatry. 2008;  41 81-91
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Diehl A, Mann K. Pharmacological relapse prevention in alcohol and tobacco dependence.  Internist (Berl). 2007;  48 79-88
    CrossrefPubMedGoogle Scholar
  • 7 Diehl A, Nakovics H, Croissant B. et al . Psychiatric liaison service in general hospitals: improvement in physicians' detection rates of alcohol use disorders.  Psychosomatics. 2008;  , [in press]
    PubMedGoogle Scholar
  • 8 Diehl A, Nakovics H, Croissant B. et al . Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.  Int J Clin Pharmacol Ther. 2006;  44 614-622
    PubMedGoogle Scholar
  • 9 Diehl A, Scherbaum N. Nicotine dependence as comorbidity of alcohol dependence – epidemiology, etiology and therapy.  Fortschr Neurol Psychiatr. 2008;  76 14-18
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ferguson JA, Patten CA, Schroeder DR. et al . Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence.  Addict Behav. 2003;  28 1203-1218
    CrossrefPubMedGoogle Scholar
  • 11 Fiore MC, Bailey WC, Cohen SJ. et al . Treating tobacco use and dependence.  Clinical Practice Guideline. U.S. Department of Health and Human Services, Public Health Service. 2000; 
    PubMedGoogle Scholar
  • 12 Fric M, Pfuhlmann B, Laux G. et al . The influence of smoking on the serum level of duloxetine.  Pharmacopsychiatry. 2008;  41 151-155
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Gershon Grand RB, Hwang S, Han J. et al . Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness.  J Clin Psychiatry. 2007;  68 892-898
    PubMedGoogle Scholar
  • 14 Heatherton TF, Kozlowski LT, Frecker RC. et al . The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire.  Br J Addict. 1991;  86 1119-1127
    CrossrefPubMedGoogle Scholar
  • 15 Hertling I, Ramskogler K, Dvorak A. et al . Craving and other characteristics of the comorbidity of alcohol and nicotine dependence.  Eur Psychiatry. 2005;  20 442-450
    CrossrefPubMedGoogle Scholar
  • 16 Hughes JR. Clinical implications of the association between smoking and alcoholism. In: Fertig J, Fuller R, eds. Alcohol and Tobacco: From Basic Science to Policy. Rockville, MD: National Institute on Alcoholism and Alcohol Abuse 1996: 171-185
    Google Scholar
  • 17 Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update.  Addiction. 2005;  100 1074-1089
    CrossrefPubMedGoogle Scholar
  • 18 Hughes JR, Novy P, Hatsukami DK. et al . Efficacy of nicotine patch in smokers with a history of alcoholism.  Alcohol Clin Exp Res. 2003;  27 946-954
    PubMedGoogle Scholar
  • 19 Hughes JR, Rose GL, Callas PW. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history.  Alcohol Clin Exp Res. 2000;  24 1633-1638
    CrossrefPubMedGoogle Scholar
  • 20 Hurt RD, Eberman KM, Croghan IT. et al . Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial.  Alcohol Clin Exp Res. 1994;  18 867-872
    PubMedGoogle Scholar
  • 21 Hurt RD, Offord KP, Croghan IT. et al . Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.  JAMA. 1996;  275 1097-1103
    CrossrefPubMedGoogle Scholar
  • 22 Hurt RD, Patten CA. Treatment of tobacco dependence in alcoholics.  Recent Dev Alcohol. 2003;  16 335-359
    PubMedGoogle Scholar
  • 23 Jimenez-Ruiz C, Solano S, Viteri SA. et al . Harm reduction – a treatment approach for resistant smokers with tobacco-related symptoms.  Respiration. 2002;  69 452-455
    CrossrefPubMedGoogle Scholar
  • 24 Joseph AM, Willenbring ML, Nugent SM. et al . A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment.  J Stud Alcohol. 2004;  65 681-691
    PubMedGoogle Scholar
  • 25 Kalman D, Hayes K, Colby SM. et al . Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery.  A pilot study. J Subst Abuse Treat. 2001;  20 233-238
    CrossrefPubMedGoogle Scholar
  • 26 Kandel D, Chen K, Warner LA. et al . Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population.  Drug Alcohol Depend. 1997;  44 11-29
    PubMedGoogle Scholar
  • 27 Kreek MJ, Nielsen DA, Butelman ER. et al . Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.  Nat Neurosci. 2005;  8 1450-1457
    CrossrefPubMedGoogle Scholar
  • 28 McIlvain HE, Bobo JK, Leed-Kelly A. et al . Practical steps to smoking cessation for recovering alcoholics.  Am Fam Physician. 1998;  57 1869-1882
    PubMedGoogle Scholar
  • 29 Olbrich R, Trager S, Nikitopoulos J. et al . Smoking reduction during inpatient alcohol detoxification.  Fortschr Neurol Psychiatr. 2008;  76 272-277
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Pakkanen JS, Jokitalo E, Tuominen RK. Up-regulation of beta2 and alpha7 subunit containing nicotinic acetylcholine receptors in mouse striatum at cellular level.  Eur J Neurosci. 2005;  21 2681-2691
    CrossrefPubMedGoogle Scholar
  • 31 Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. In: Hersen M, Eisler RM, Miller PM, eds. Progress in behavior modifications. Sycamore: Sycamore Press 1992
    Google Scholar
  • 32 Schroter M, Collins SE, Frittrang T. et al . Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers.  Addict Behav. 2005; 
    PubMedGoogle Scholar
  • 33 Skinner HA, Allen BA. Alcohol dependence syndrome: measurement and validation.  J Abnorm Psychol. 1982;  91 199-209
    PubMedGoogle Scholar
  • 34 Tiffany ST, Drobes DJ. The development and initial validation of a questionnaire on smoking urges.  Br J Addict. 1991;  86 1467-1476
    CrossrefPubMedGoogle Scholar
  • 35 Toneatto A, Sobell LC, Sobell MB. et al . Effect of cigarette smoking on alcohol treatment outcome.  J Subst Abuse. 1995;  7 245-252
    CrossrefPubMedGoogle Scholar
  • 36 Wennike P, Danielsson T, Landfeldt B. et al . Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.  Addiction. 2003;  98 1395-1402
    CrossrefPubMedGoogle Scholar

Correspondence

A. DiehlMD 

Department of Addictive Behavior and Addiction Medicine

Central Institute of Mental Health Mannheim

University of Heidelberg

Square J 5

68159 Mannheim

Germany

Phone: +49/621/1703 35 42

Fax: +49/621/1703 35 45

Email: alexander.diehl@zi-mannheim.de

      >